University of Utah
The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).
Inclusion Criteria: * Female subjects aged ≥ 18 years. * Histologically confirmed breast or gynecologic cancer. * Developed neuropathic pain with the initiation of or within one month after completion of treatment with anti-neoplastic agents from the following class: * Platinum-based drugs * Taxanes * Vinca alkaloids * Pain score 4 or more on the Pain Numeric Rating Scale (PNRS). * Score 3 or more on the Douleur Neuropathique 4 (DN-4) questionnaire. * Subjects must have failed at least one standard-of-care neuropathic medication. \--- Note: Failure is defined as discontinuation of t…
Repetitive Transcranial Magnetic Stimulation will be administered Monday-Friday for two weeks (10 sessions total)
Arctuva estimate
Verify or correct the compensation shown for this listing.